Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Accumulated Expenses: 2023-2025

Historic Accumulated Expenses for Camp4 Therapeutics (CAMP) over the last 1 years, with Sep 2025 value amounting to $4.1 million.

  • Camp4 Therapeutics' Accumulated Expenses rose 10.55% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 10.55%. This contributed to the annual value of $4.8 million for FY2024, which is 46.37% up from last year.
  • Per Camp4 Therapeutics' latest filing, its Accumulated Expenses stood at $4.1 million for Q3 2025, which was up 41.64% from $2.9 million recorded in Q2 2025.
  • Camp4 Therapeutics' 5-year Accumulated Expenses high stood at $4.8 million for Q4 2024, and its period low was $1.8 million during Q1 2025.
  • Its 3-year average for Accumulated Expenses is $3.4 million, with a median of $3.5 million in 2023.
  • Data for Camp4 Therapeutics' Accumulated Expenses shows a peak YoY spiked of 46.37% (in 2024) over the last 5 years.
  • Camp4 Therapeutics' Accumulated Expenses (Quarterly) stood at $3.3 million in 2023, then skyrocketed by 46.37% to $4.8 million in 2024, then grew by 10.55% to $4.1 million in 2025.
  • Its last three reported values are $4.1 million in Q3 2025, $2.9 million for Q2 2025, and $1.8 million during Q1 2025.